Every Organ Wasted is a Life Not Saved. TransMedics, Inc. is a commercial-stage medical technology company transforming organ transplant therapy for patients worldwide. Our mission is to help save more patients’ lives by increasing access to viable donor organs for those who are awaiting an organ transplant. To accomplish this mission, we partner closely with transplant stakeholders worldwide and help expand their access to healthy donor organs, while delivering the highest quality technology, service, and clinical care. With more than 25 years of commitment to excellence and innovation, TransMedics is at the forefront of advancing the field of organ transplantation. Our innovative Organ Care System (OCS™) technology is the only FDA-approved technology for lung, heart and liver transplant indications in the U.S., enabling the optimization and assessment of donor organs outside the human body and replacing a decades-old outdated standard of care: static cold storage (ice). Combined with our National OCS Program (NOP), a nationwide team of clinical experts, 24/7 logistics support, and the first-of-its-kind dedicated air & ground transport logistics network, we are enabling transplant centers to expand their search criteria for viable organ donors and grow overall transplant volumes in the U.S. www.TransMedics.com
External link for TransMedics, Inc.
200 Minuteman Road
Suite 302
Andover, MA 01810, US
TransMedics, Inc. reposted this
TMDX was featured at Investors Business Daily. We are honored and humbled by our success to-date. We must remember that we are still early and we have a long runway of growth ahead to maximize the availability of healthy donor organs to help patients in need for organ transplants globally! TMDX team is working tirelessly to achieve this vision!
TransMedics, Inc. reposted this
Our industry partners make the #ISHLT2024 Annual Meeting possible. Today, we recognize Pinnacle-level Supporter TransMedics, Inc. for their support of the Annual Meeting. You can see TransMedics on-site in Prague at booth 13.
Here is another real world positive impact of TransMedics’ OCS Liver and NOP to increase utilization of DCD livers for transplantation. In 2023, the US liver transplant volume grew by 12% primarily because of this impact. Again, TMDX NOP can do more to continue to drive additional growth in liver, heart and lung transplants in the US! We are grateful for donor families, our transplant centers who entrusted to procure and manage OCS perfusion for them and our world-class TMDX Team who is making this transformation a clinical reality!
It's encouraging to see non-utilization rates decreasing for hearts (left) and livers (right) from DCD donors. As far as I can tell, this is primarily driven by innovation/technology/change in practice and not by any particular policy aimed at decreasing non-utilization. As someone who thinks a lot about policy, and how policy can be crafted to achieve certain ends (e.g., decreasing non-utilization), things like this always give me pause.
The OCS Heart and NOP were used for ~70% of the DCD heart transplanted in the US in 2023, resulting in the lion’s share of the 13% growth of the national heart transplant volume in 2023! We can do more! Grateful to donor families, our clinical users and our world-class NOP clinical and logistics teams!
Finally, there is now a little bit of information around normothermic regional perfusion (NRP) in the Donation and Transplant System Explorer. NRP is not explicitly captured as a data element, so we inferred NRP if the time from declaration of death to cross clamp is longer than 30 minutes for DCD donors. Below is the trend of DCD heart transplants stratified by whether the transplant was done with or without NRP. https://lnkd.in/gBq95htt
TMDX world-class NOP clinical and aviation teams coming together to deliver precious donor organs to patients in need across the US! Keep up the great work Team TMDX!
Another dedicated hardworking OCS Team. Thank you Sadie and Taylor for all you do, offering the best transplant logistics available today. Just completed another successful mission Kentucky to California.
Congratulations to the Tufts Heart Transplant program and team for their success in growing their volumes with the help of TransMedics Heart NOP program. We are proud to be their partners and excited to continue supporting their growth in 2024. OCS NOP eliminates historical cold ischemia time and distance limitations, enabling more distant procurement of donor organs that historically were seldomly used for transplants. Thanks to the hard work of the TMDX NOP and Logistics team, we are shaping the future of organ transplantation in the US. #TransMedics #HeartNOP #Beatinghearttransplants #Heartinabox #OrganTransplantation #HealthcarePartnerships
TransMedics NOP program is expanding the reach and capabilities of transplant programs across the US to grow their transplant volumes to help patients in need. Here is our TMDX NOP Team supporting 3 organs for a major SE transplant program and another TMDX NOP Team supporting 4 organs at a major SW transplant program in the US! Shout out to our dedicated TMDX NOP teams across the US and our logistics teams who are making these cases a clinical reality every day. Keep up the GREAT work. TMDX NOP is redefining whats possible in organ transplants!